Indian Immunologicals Limited
Indian Pharmaceutical Exporter ยท Other Specialist ยท $29.1M Total Trade ยท DGFT Verified
Indian Immunologicals Limited is an Indian pharmaceutical exporter with a total trade value of $29.1M across 3 products in 3 therapeutic categories. Based on 581 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Vaccine ($20.1M), Syringe ($8.3M), Extract ($600.0K).
Indian Immunologicals Limited โ Export Portfolio & Destination Treemap

Who is Indian Immunologicals Limited? โ Company Overview & Market Position
Indian Immunologicals Limited (IIL) is a prominent biotechnology company based in Hyderabad, Telangana, India. Established in 1982 by the National Dairy Development Board (NDDB), IIL was incorporated as a public limited company in 1999 under the Corporate Identification Number (CIN) U72200TG1999PLC032666. The company specializes in the development and manufacturing of vaccines and other immunobiological products, serving both human and veterinary sectors. IIL's product portfolio includes over 150 items, with a significant presence in the Indian market and exports to more than 50 countries.
As a subsidiary of the NDDB, IIL operates with a mission to make biotechnology in healthcare affordable and accessible. The company's authorized capital is โน400 crore, with a paid-up capital of โน54 crore. IIL employs between 1,000 and 5,000 individuals, reflecting its substantial operational scale. The company's official website is www.indimmune.com.